(Q46583591)

English

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).

scientific article published on 20 May 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

type 2 diabetes

0 references

0 references

glucose monitoring

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A H Barnett

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

A J Krentz

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

K Strojek

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

J Sieradzki

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

F Azizi

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

M Embong

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

S Imamoglu

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

J Perusicová

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

V Uliciansky

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

G Winkler

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

publication date

20 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

1239-1247

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

The Efficacy of Self-Monitoring of Blood Glucose in NIDDM subjects: A criteria-based literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self monitoring of glucose by people with diabetes: evidence based practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring in Type 2 diabetes mellitus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Establishment of blood glucose monitoring system using the internet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose in type 2 diabetes: time for evidence of efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Point: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Gliclazide modified release: results of a 2-year study in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Diamicron MR once daily is effective and well tolerated in type 2 diabetes: a double-blind, randomized, multinational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Revealing the cost of Type II diabetes in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Management of dyslipidemia in children and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2008.00894.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2008.00894.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18494813

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46583591&oldid=1569860711"